Column Group LLC Long-Term Concentrated

CIK: 0001833486 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 13, 2023

Total Value ($000): $300,399 (100.0% shares, 0.0% debt)

Holdings (7)

RVMD Revolution Medicines Inc 36.3%

Value ($000) $109,044 Shares 4,577,840 Est. Cost $34.24 Unrealized -37.9%

— NGM Biopharmaceuticals Inc 30.3%

Value ($000) $91,046 Shares 18,136,735 Est. Cost $27.77 Unrealized —

— RAPT Therapeutics Inc 17.7%

Value ($000) $53,076 Shares 2,680,621 Est. Cost $19.03 Unrealized —

ORIC ORIC Pharmaceuticals Inc. 7.0%

Value ($000) $21,017 Shares 3,568,181 Est. Cost $28.69 Unrealized -88.2%

TNYA Tenaya Therapeutics, Inc. 6.3%

Value ($000) $18,895 Shares 9,400,290 Est. Cost $21.49 Unrealized -88.6%

— Surrozen, Inc. 1.8%

Value ($000) $5,478 Shares 9,414,795 Est. Cost $6.95 Unrealized —

— eFFECTOR Therapeutics Inc 0.6%

Value ($000) $1,843 Shares 4,309,329 Est. Cost $14.05 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
RVMD	Revolution Medicines Inc	4,577,840	$109,044	36.3%	$34.24	-37.9%	COM	76155X100
—	NGM Biopharmaceuticals Inc	18,136,735	$91,046	30.3%	$27.77	—	COM	62921N105
—	RAPT Therapeutics Inc	2,680,621	$53,076	17.7%	$19.03	—	COM	75382E109
ORIC	ORIC Pharmaceuticals Inc.	3,568,181	$21,017	7.0%	$28.69	-88.2%	COM	68622P109
TNYA	Tenaya Therapeutics, Inc.	9,400,290	$18,895	6.3%	$21.49	-88.6%	COM	87990A106
—	Surrozen, Inc.	9,414,795	$5,478	1.8%	$6.95	—	COM	86889P109
—	eFFECTOR Therapeutics Inc	4,309,329	$1,843	0.6%	$14.05	—	COM	28202V108